-
- Posts: 108
- Joined: Fri Sep 03, 2004 3:42 pm
I have a tablet formulation containing 4 actives, one of them being Caffeine. During our validation we were unable to achieve acceptable method precision for the caffeine. The combined %RSD for the method precision (6 assays from each analysts) is greater than 2% for caffeine. The %RSD for the other 3 actives are all below 1%. We have tried various other methods e.g. USP and BP methods to improve the method precision but have had no success. The formulators are insisting that the analytical method is the problem? The lab analysts think it is the product because 3 of 4 actives are well within the method precision requirements. Could the particle size of the caffeine have an influence on the method precision? Has anyone had similar problems when analysing caffeine?
Thanks in advance
Mike